The World Health Organization sets a cervical-cancer elimination goal

A goal no one had set before

In August 2020 the World Health Assembly adopted a global strategy to eliminate cervical cancer as a public health problem. It was the first time the world's health ministers agreed to try to end a specific cancer.

WHO noted at the time that nearly 90 percent of deaths from the disease in 2018 happened in low- and middle-income countries. In those countries, more than 60 percent of women diagnosed died of it. That share is more than twice the figure in wealthier countries.

What "elimination" means here

It does not mean zero cases. WHO set a numeric threshold. Every country must reach and hold an incidence rate below 4 new cases per 100,000 women.

Three targets, to be met by 2030, are meant to get there. They are known as 90-70-90:

• 90 percent of girls fully vaccinated against HPV by age 15.
• 70 percent of women screened with a high-performance test by age 35, and again by age 45.
• 90 percent of women with pre-cancer treated, and 90 percent with invasive cancer managed.

Two of those three targets are about prevention. Only the last is about treating cancer.

Why this cancer and not another

Almost all cervical cancer is caused by one virus. Human papillomavirus, or HPV, is a group of more than 200 related viruses. NCI notes that more than 40 spread through direct sexual contact, and that about a dozen types can cause cancer.

Most HPV infections clear on their own. When a high-risk type persists for years, it can change cervical cells, and those changes can become cancer over a long period. That slow path is what makes the disease attackable. There is a vaccine for the cause, and a test that finds the changes before they turn into cancer.

The vaccine half

The vaccine used in the United States is Gardasil 9. NCI reports that CDC recommends it for children and adults aged 9 through 26. It is routinely given at age 11 or 12, and can start at 9.

NCI is also clear about what it does not do. It protects against types a person has not yet caught. It does not cure an existing HPV infection, and it does not treat an abnormal Pap result. That is why age at vaccination matters.

The screening half

Screening finds changes before they are cancer. NCI notes that early cervical cancer usually causes no symptoms at all, which is exactly why a test is needed.

In the United States, the Preventive Services Task Force recommends screening every three years with cervical cytology, the Pap test, for women aged 21 to 29. For ages 30 to 65 it recommends one of three options: cytology every three years, high-risk HPV testing every five years, or both together every five years.

Our guide to cervical cancer screening explains what each test looks for and what an abnormal result actually starts.

What this looks like in one country

The United States is not close to WHO's threshold, though it is closer than most of the world. The American Cancer Society projects about 13,490 new cervical cancer cases and 4,200 deaths in 2026, a figure SEER reprints.

Five-year relative survival is 68.8 percent overall for people diagnosed from 2016 to 2022. About 41 percent of cases are found while still confined to the cervix, where five-year relative survival is 91.8 percent. It is 64.0 percent once regional lymph nodes are involved, and 20.5 percent when the cancer has spread to distant sites. These are group averages, not predictions for an individual. The gap between 91.8 and 20.5 is the argument for screening in one line.

Symptoms, and why they come late

NCI lists these symptoms, and notes they usually begin only after the cancer has spread:

• vaginal bleeding after sex.
• vaginal bleeding after menopause.
• bleeding between periods, or periods heavier or longer than usual.
• vaginal discharge that is watery, strong-smelling, or bloody.
• pelvic pain, or pain during sex.

Any of these needs an appointment, whatever your screening history. But waiting for them is the wrong strategy. Keeping to the screening schedule is the point. Our overview of cervical cancer covers what happens after an abnormal result.

What this does not mean

• A global target is not a forecast. Progress depends on vaccine supply, health systems, and money.
• The threshold of 4 per 100,000 is a population measure. It says nothing about one person's risk.
• Vaccination does not replace screening. People who are vaccinated still follow the screening schedule.
• HPV is very common, and most infections never cause cancer. A positive HPV test is not a cancer diagnosis.

Sources

• WHO: World Health Assembly adopts global strategy to accelerate cervical cancer elimination
• WHO: Cervical Cancer Elimination Initiative
• NCI: HPV Vaccine Fact Sheet
• NCI: Cervical Cancer Symptoms
• USPSTF: Cervical Cancer Screening recommendation
• SEER Cancer Stat Facts: Cervical Cancer

How this page was made

An AI-assisted editorial system helped prepare this page. This article has not been reviewed by a healthcare professional unless a named reviewer is specifically shown. Cancer Explained is published by the National Cancer Information Foundation as a nonprofit-oriented public-interest education project. It is not a diagnostic service, does not recommend treatments, and is not for emergencies.

Found an error, a broken source link, outdated information, or wording that feels insensitive? Report it here — we log and act on material corrections.